Eli Lilly & Co. (LLY) completes takeover of Sigilon Therapeutics (SGTX) Aug 14, 2023 07:27AM
Lilly Completes Acquisition of Sigilon Therapeutics Aug 14, 2023 07:25AM
Eli Lilly & Co. (LLY) to Acquire Sigilon Therapeutics (SGTX) for $14.92/sh plus CVR Jun 29, 2023 06:46AM
Lilly to Acquire Sigilon Therapeutics Jun 29, 2023 06:45AM
Kytopen Announces Foundation of New Scientific Advisory Board Joined by Cullen Buie, Ph.D., Omid Veiseh, Ph.D., Stanley Qi, Ph.D., Katie Galloway, Ph.D., Ahmad S. Khalil, Ph.D., and Jared Auclair, Ph. Jan 9, 2023 09:00AM


Feb 15, 2022 10:05AM INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
Jan 26, 2022 09:31AM Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
Oct 13, 2021 10:11AM Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change